WEIR Science

Weir Science is a New Zealand-based biotechnology company specializing in cellular health and the regulation of apoptosis. Founded by cell biologist Dr. Iona Weir, the company utilizes its proprietary Myrecil platform—a biologically fermented technology—to develop non-hormonal products for dermatology, gut health, and postmenopausal urogenital health. Its commercial portfolio includes the Atopis skin care range and Myregyna, a dual-action system designed to support women's health during and after menopause. The company's research focuses on resetting natural cellular renewal and defense systems to address conditions like eczema and vaginal atrophy. Weir Science operates with a focus on botanical drug discovery and immune modulation, maintaining a presence in both the New Zealand and United States markets.